Benitec Biopharma Inc. (BNTC) Q1 2024 Earnings
BNTC·Reported May 13, 2024·Before market open
Benitec Biopharma Inc. reported Q1 2024 revenue of $3.9K. Diluted EPS came in at $-1.64, missed the $-0.78 consensus by $0.86.
Revenue
$3.9K
Diluted EPS
$-1.64missed by $0.86
Consensus: $-0.78
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Benitec Biopharma Inc.'s Q1 2024 earnings report.
Benitec Biopharma Inc. (BNTC) reported Q1 2024 earnings on May 13, 2024 before market open.
Benitec Biopharma Inc. reported revenue of $3.9K and diluted EPS of $-1.64 for Q1 2024.
EPS missed the consensus estimate of $-0.78 by $0.86.
You can read the 10-Q periodic report (0001193125-24-136727) directly on SEC EDGAR. The filing index links above go to sec.gov.